dichlororibofuranosylbenzimidazole has been researched along with Acute Promyelocytic Leukemia in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vyginnyĭ, SM | 1 |
| Abramov, EA | 1 |
| Mamaeva, SE | 1 |
| Rasheed, ZA | 1 |
| Saleem, A | 1 |
| Ravee, Y | 1 |
| Pandolfi, PP | 1 |
| Rubin, EH | 1 |
| Kaufmann, SH | 1 |
3 other studies available for dichlororibofuranosylbenzimidazole and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
[The dependence of the quantity of silver granules detectable in interphase nuclei after the silver nitrate staining of the chromosomal nucleolus-organizer regions on the conditions for the hypotonic treatment of the cells and the effect on this index of
Topics: Cells, Cultured; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Fibroblasts; | 1993 |
The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Topics: Amino Acid Sequence; Animals; Binding Sites; Camptothecin; Carrier Proteins; Cell Nucleus; Chromosom | 2002 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; | 1991 |